US 10874659
Iloperidone metabolite for use in the treatment of psychiatric disorders
granted A61KA61K31/454A61P
Quick answer
US patent 10874659 (Iloperidone metabolite for use in the treatment of psychiatric disorders) held by VANDA PHARMACEUTICALS INC. expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/454, A61P, A61P25/18